` NEU (Neuca SA) vs WIG20 Comparison - Alpha Spread

N
NEU
vs
W
WIG20

Over the past 12 months, NEU has underperformed WIG20, delivering a return of -9% compared to the WIG20's +28% growth.

Stocks Performance
NEU vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NEU vs WIG20

Loading
NEU
WIG20
Difference
www.alphaspread.com

Performance By Year
NEU vs WIG20

Loading
NEU
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Neuca SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Neuca SA
Glance View

Market Cap
3.7B PLN
Industry
Health Care

NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie and currently employs 3,852 full-time employees. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.

NEU Intrinsic Value
1 358.61 PLN
Undervaluation 40%
Intrinsic Value
Price
N
Back to Top